Review urges oral health focus in CKD care
CINCINNATI, US: Oral health remains largely absent from chronic kidney disease (CKD) care, despite evidence that patients with CKD often have a high burden of oral disease and may experience…
Trial Dims Prospects for Rivaroxaban’s Cardiovascular Protection in Advanced CKD
TRACK was the first dedicated placebo-controlled trial to test an anticoagulant for protection from hard cardiovascular outcomes in patients with advanced CKD at high cardiovascular risk. In this population, historically…
